Colleen Niswender, Ph.D., research associate professor of Pharmacology, has received a three-year, $450,000 grant from the autism science and advocacy organization Autism Speaks to support studies investigating a possible new treatment for Rett syndrome.

According to annual figures available through the National Institutes of Health (NIH), Vanderbilt University School of Medicine (VUSM) is now ranked ninth in the nation among U.S. medical schools in total grant support provided through the nation’s medical research agency.

Vanderbilt University researchers have discovered a “backdoor” approach to blocking an enzyme that fuels the growth of glioblastoma, the most common and most fatal form of brain cancer.

Neurodevelopmental outcomes of premature infants with post-hemorrhagic hydrocephalus is the subject of a new research study at the Monroe Carell Jr. Children’s Hospital at Vanderbilt.

In preliminary testing, Vanderbilt Home Care Services (VHCS) has found that Internet-based remote patient monitoring reduces hospital readmissions for patients with congestive heart failure (CHF) who are receiving home nursing visits.

Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.